Chat
Feedback
Settings

Settings

Goto Application

1. WO2022162439 - LACTOBACILLUS RHAMNOSUS LRH05 ISOLATE, AND COMPOSITION INCLUDING THE SAME AND USE THEREOF

Submit observation
PermaLink
Publication Number WO/2022/162439
Publication Date 04.08.2022
International Application No. PCT/IB2021/055352
International Filing Date 17.06.2021
IPC
C12N 1/20 2006.1
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
1Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
20Bacteria; Culture media therefor
A61K 35/747 2015.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
35Medicinal preparations containing materials or reaction products thereof with undetermined constitution
66Microorganisms or materials therefrom
74Bacteria
741Probiotics
744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
747Lactobacilli, e.g. L. acidophilus or L. brevis
A61P 1/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 3/10 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 29/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs)
A61P 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
CPC
A23C 11/106
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
CDAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
11Milk substitutes, e.g. coffee whitener compositions
02containing at least one non-milk component as source of fats or proteins
10containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
103containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
106Addition of, or treatment with, microorganisms
A23C 19/00
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
CDAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
19Cheese; Cheese preparations; Making thereof
A23C 9/1234
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
CDAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
9Milk preparations; Milk powder or milk powder preparations
12Fermented milk preparations; Treatment using microorganisms or enzymes
123using only microorganisms of the genus lactobacteriaceae; Yoghurt
1234characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
A23G 3/366
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
3Sweetmeats; Confectionery; Marzipan; Coated or filled products
34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
36characterised by the composition ; containing organic or inorganic compounds
364containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
366containing microorganisms, enzymes
A23G 9/363
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
9Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
32characterised by the composition ; containing organic or inorganic compounds
36containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
363containing microorganisms, enzymes
A23K 10/16
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
KFODDER
10Animal feeding-stuffs
10obtained by microbiological or biochemical processes
16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
Applicants
  • SYNBIO TECH INC. [CN]/[CN]
Inventors
  • CHEN, Yung-Tsung
  • LIN, Jin-seng
Agents
  • XU & PARTNERS, LLC.
Priority Data
11010312427.01.2021TW
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) LACTOBACILLUS RHAMNOSUS LRH05 ISOLATE, AND COMPOSITION INCLUDING THE SAME AND USE THEREOF
(FR) ISOLAT DE LACTOBACILLUS RHAMNOSUS LRH05 ET COMPOSITION COMPRENANT CELUI-CI ET SON UTILISATION
front page image
Abstract
(EN) Disclosed herein is an isolated strain of Lactobacillus rhamnosus LRH05, which is deposited at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH under an accession number DSM 33616. Also disclosed herein are a composition including the isolated strain of Lactobacillus rhamnosus LRH05 for treating a metabolic syndrome-related disorder and for modifying gut microbiota, and use of the isolated strain of Lactobacillus rhamnosus LRH05 for treating a metabolic syndrome-related disorder and for modifying gut microbiota.
(FR) La présente invention concerne une souche isolée de Lactobacillus rhamnosus LRH05, qui est déposée auprès de la Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH sous le numéro d'entrée DSM 33616. La présente invention concerne également une composition comprenant la souche isolée de Lactobacillus rhamnosus LRH05 pour le traitement d'un trouble lié au syndrome métabolique et pour la modification du microbiote intestinal et l'utilisation de la souche isolée de Lactobacillus rhamnosus LRH05 pour le traitement d'un trouble lié au syndrome métabolique et pour la modification du microbiote intestinal.
Related patent documents
CN114891654
Latest bibliographic data on file with the International Bureau
# -